Cite
Basile D, Gallois C, Puglisi F, et al. Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. Clin Res Hepatol Gastroenterol. 2021;45(3):101681doi: 10.1016/j.clinre.2021.101681.
Basile, D., Gallois, C., Puglisi, F., Cohen, R., Goere, D., Aprile, G., Lepage, C., Laurent-Puig, P., Di Maio, M., Lecomte, T., Pernot, S., Zaanan, A., & Taieb, J. (2021). Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. Clinics and research in hepatology and gastroenterology, 45(3), 101681. https://doi.org/10.1016/j.clinre.2021.101681
Basile, Debora, et al. "Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey." Clinics and research in hepatology and gastroenterology vol. 45,3 (2021): 101681. doi: https://doi.org/10.1016/j.clinre.2021.101681
Basile D, Gallois C, Puglisi F, Cohen R, Goere D, Aprile G, Lepage C, Laurent-Puig P, Di Maio M, Lecomte T, Pernot S, Zaanan A, Taieb J. Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. Clin Res Hepatol Gastroenterol. 2021 May;45(3):101681. doi: 10.1016/j.clinre.2021.101681. Epub 2021 Mar 27. PMID: 33785445.
Copy
Download .nbib